NINTEDANIB Pharmacologic Class Indexing
- Class set ID
- e2bf45a9-1b02-4e07-aecc-7d661ebcd6d9
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | EXELAN PHARMACEUTICALS INC. | Cipla Limited | CIPLA LIMITED VIRGONAGAR | Douglas Manufacturing Limited | 20260421 | 1 |
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | Edenbridge Pharmaceuticals LLC. | 20260415 | 2 |
| NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | Golden State Medical Supply, Inc. | 20260406 | 1 |
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | Cipla USA Inc. | Cipla Limited | CIPLA LIMITED GOA | CIPLA LIMITED VIRGONAGAR | CIPLA LIMITED KURKUMBH | 20260402 | 3 |
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | Apotex Corp. | 20260320 | 1 |
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | Sandoz Inc | 20260120 | 2 |
| These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories Limited, FTO-SEZ - Process Unit-02 | 20251120 | 4 |
| These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | Boehringer Ingelheim Pharmaceuticals, Inc. | 20251120 | 21 |